

1,401,948 filings since 2004 · latest accepted Nov 4, 2026, 6:23 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Jul 14, 2025 accepted 7:30 AM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jul 11, 2025 accepted 6:12 AM ET | MISTMilestone Pharmaceuticals Inc. | Material agreement |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Mar 18, 2025 accepted 4:25 PM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jul 15, 2024 accepted 4:02 PM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement5.02Officer / director change5.08Director nominations8.01Other events | DocumentSEC ↗ |
Mar 4, 2024 accepted 9:00 AM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Mar 28, 2023 accepted 7:00 AM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 27, 2023 accepted 5:17 PM ET | MISTMilestone Pharmaceuticals Inc. | 1.01Material agreement3.02Unregistered equity sale5.02Officer / director change | DocumentSEC ↗ |